You are here: Industry Insights > New Drug

News List

Where Lies the Competitiveness of China's New Drugs for Central Nervous System? Prof. Zhang
October 18, 2024
The Global Challenges and Opportunities of the R&D of New Drugs for Central Nervous System
Research Progress on the Pharmacological Effects and New Drug Forms of Artemisinin and Its Derivatives Xiaomichong
July 19, 2024
Artemisinin is a sesquiterpene lactone compound with a peroxide group structure extracted from the leaves of Artemisia annua, a plant belonging to the Asteraceae family.
A Brief Introduction to Drug Treatment and New Drug Development for Chronic Cough Xiaomichong
July 15, 2024
Chronic cough (CC) is a common disease with a prevalence rate of up to 12%, significantly affecting the quality of life of patients.
Research Progress on the Mechanism of Hypertension and New Drug Development Xiaomichong
July 08, 2024
October 8th of every year is National Hypertension Day. Hypertension is a cardiovascular syndrome with elevated arterial pressure as its main clinical manifestation.
Hengrui's Application for New Class 1.1 Drug Hetrombopag Ethanolamine Tablets was Accepted by CDE PharmaSources/Dopine
June 19, 2020
On June 18, the marketing application of Hengrui's new class 1.1 drug Hetrombopag ethanolamine tablets was accepted by CDE.
Eurofins CDMO Expands Drug Product Capabilities in Canada contractpharma
November 06, 2020
Eurofins CDMO has expanded its existing drug product operation capabilities with the early 2020 completion of its new drug product development and cGMP manufacturing facility, located in Mississauga, Canada.
FDA new drug approvals down 16 percent in 2019, impacting outsourcing europeanpharmaceuticalreview
May 14, 2020
A new report has found that in 2019 the FDA approved 119 new drugs and biologics, but that this is down from 137 in 2018, impacting contract manufacturing organisations.
Harvest in 2019 year-end with the Marketing of Multiple Generic Drugs PharmaSources/Caicai
January 07, 2020
The NMPA is also “sprinting” as the year is coming to an end.
Gatehouse Bio collaborates with AstraZeneca to accelerate new drug discovery pharmaceutical-business-review
December 11, 2019
Gatehouse Bio, a pioneer in next-generation therapeutics, is collaborating with AstraZeneca, a global science-led biopharmaceutical company, to explore the identification of new targets ...
Shanghai Green Valley’s Class 1 New Drug for Alzheimer’s Disease Conditionally Approved for Marketing and Already Having the Registration Approval! PharmaSources/Caicai
November 14, 2019
The National Medical Products Administration of China (NMPA) released on its website yesterday (Nov. 2, 2019) some big news that shocks the industry.

Previous page 1 2 3 Next page